haylaavo

J B CHEMICALS AND PHARMA

JBCHEPHARM · NSE · inactive
2,408.90
-97.10 (-3.87%)
as of 16 Jul 2026 close
Open
2,506.00
High
2,525.50
Low
2,380.00
Prev close
2,506.00
52w high
2,525.50
16 Jul 2026
52w low
1,638.50
26 Sept 2025
VWAP
2,418.56
Delivery %
66.8%
of volume
Volume 47.79 L · turnover ₹1155.88 Cr · NSE bhavcopy (official close), adjusted for splits/bonuses · history since 02 Feb 1995
Series
EQ
F&O
No
Status
Inactive since 17 Jul 2026

Source: NSE equity master · as of 16 Jul 2026

Market cap
—
P/B
—
ROE (TTM)
17.1%
ROCE 23.0%
Debt / equity
0.00
P/E (TTM)
—
P/S (TTM)
—
Revenue TTM
₹4,148 cr
Net profit TTM
₹709 cr
Net margin TTM
17.1%
OPM 26.0%
EV / EBITDA
—
Interest cover
172.0×
Revenue growth
-4.8%
latest quarter YoY
Profit growth
-30.4%
latest quarter YoY
Dividend yield
—
₹22 / share · payout —

Consolidated · last four quarters to 2026-03-31 · balance sheet 2026-03-31 · tap a tile for the formula

Daily · NSE EOD
Exchange announcements
Source: NSE corporate filings · latest Today 20:40 IST
AllM&AAGM / meetingAnalyst meetBoard meetingBusiness updateManagementComplianceCorporate actionCredit ratingDividendExchange queryGeneral updateInsider / SASTLegalOrder winResults
  • 08 Jul 11:32
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about General Updates

    PDF · 376.98 KB
  • 07 Jul 18:03
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about General Updates

    PDF · 377.69 KB
  • 06 Jul 18:49
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about General Updates

    PDF · 373.45 KB
  • 15 Jun 17:55
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about update on intimation dated June 12, 2026

    PDF · 385.82 KB
  • 27 May 18:34
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Letter to Shareholders - Integrated Annual Report 2025-26'.

    PDF · 505.56 KB
  • 25 May 18:37
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding BRSR FY 26''.

    PDF · 5.65 MB
  • 28 Mar 20:07
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper Publication- Notice to Equity Shareholders

    PDF · 3.98 MB
  • 05 Feb 18:55
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Change in Key Managerial Personnel - Letter of Resignation

    PDF · 675.00 KB
  • 21 Jan 21:40
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Corrigendum to the Outcome of the first Board Meeting held on 21 January 2026

    PDF · 319.42 KB
  • 21 Jan 15:49
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about General Updates

    PDF · 1.59 MB
  • 07 Jan 14:54
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about additional investment in wholly-owned subsidiary

    PDF · 356.48 KB
  • 24 Dec 2025 17:27
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015- Receipt of Order

    PDF · 320.53 KB
  • 22 Dec 2025 18:58
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about DJSI (Dow Jones Sustainable Index) ESG Score release

    PDF · 286.82 KB
  • 16 Dec 2025 13:42
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015- Receipt of Order

    PDF · 311.82 KB
  • 17 Nov 2025 19:07
    General update

    NovaaOne Capital Private Ltd has submitted to  the Exchange a copy of offer opening advertisement under Regulation 18(7) of SEBI (SAST) Regulations, 2011 as amended (SEBI(SAST) Regulations) and Corrigendum to the detailed public statement for the attention of the eligible shareholders of the company

    PDF · 7.73 MB
  • 12 Nov 2025 18:49
    General update

    JB Chemicals & Pharmaceuticals Limited has submitted to  the Exchange a copy of Recommendation of the committee of Independent Director ( IDC) of the company on the open offer(as defined below) made by torrent pharmaceuticals ltd to the eligible shareholders of the company, under Regulation 26(7) of Securities and Exchange Board of India (SAST) Regulations, 2011 and subsequent amendments thereto ( SEBI (SAST) Regulations")

    PDF · 7.44 MB
  • 07 Nov 2025 11:35
    General update

    NovaaOne Capital Private Limited has Submitted to the Exchange a copy of Letter of Offer.

    PDF · 1.03 MB
  • 24 Oct 2025 15:47
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding '4th Sustainability (ESG) Report'.

    PDF · 47.72 MB
  • 08 Sept 2025 17:40
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Disclosure under Regulation 30 of the SEBI (Listing obligations and Disclosure Requirements), Regulations, 2015

    PDF · 320.63 KB
  • 06 Aug 2025 20:01
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Change in Registered Office

    PDF · 3.53 MB
  • 17 Jul 2025 19:37
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Letter To Shareholders - Integrated Annual Report FY 2024-25'.

    PDF · 1.14 MB
  • 30 Jun 2025 24:56
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Public Announcement of open offer for acquisition of Company s equity shares

    PDF · 941.59 KB
  • 29 Jun 2025 20:00
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Change of Registered Office

    PDF · 713.06 KB
  • 24 Jun 2025 18:26
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'ANDA Approval by US FDA'.

    PDF · 3.51 MB
  • 14 May 2025 20:25
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Appointment of Secretarial Auditor

    PDF · -
  • 14 May 2025 20:25
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about re-appointment of Statutory Auditor

    PDF · -
  • 18 Apr 2025 14:30
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'ANDA Approval by US FDA'.

    PDF · -
  • 02 Apr 2025 17:34
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Noting of Cautionary letter received from the Exchanges'.

    PDF · -
  • 02 Apr 2025 17:31
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015

    PDF · -
  • 29 Mar 2025 15:44
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

    PDF · -
  • 14 Mar 2025 16:49
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'USFDA inspection of Company s API manufacturing facility D9 at Panoli, Gujarat'.

    PDF · -
  • 08 Mar 2025 16:37
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'USFDA inspection of Company s manufacturing facility T20 at Panoli, Gujarat'.

    PDF · -
  • 05 Mar 2025 14:47
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'DJSI (Dow Jones Sustainable Index) ESG Score release'.

    PDF · -
  • 28 Feb 2025 10:57
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015

    PDF · -
  • 19 Feb 2025 16:43
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Intimation of schedule of Analysts/Institutional investors meet

    PDF · -
  • 19 Feb 2025 16:38
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015

    PDF · -
  • 04 Feb 2025 19:36
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Board comments on fine levied by the Exchange for delayed compliance'.

    PDF · -
  • 04 Feb 2025 17:00
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015

    PDF · -
  • 16 Jan 2025 16:10
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015'.

    PDF · -
  • 16 Jan 2025 16:10
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Presentation'.

    PDF · -
  • 06 Dec 2024 16:16
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Allotment of Equity Shares on exercise of Stock options pursuant to Employee Stock Option Scheme'.

    PDF · -
  • 06 Nov 2024 19:47
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Board commentson fine levied by the Exchange'.

    PDF · -
  • 21 Oct 2024 16:46
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding '3rd Sustainability (ESG) Report '.

    PDF · -
  • 06 Sept 2024 16:06
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Intimation Of Schedule Of Analysts/Institutional Meet'.

    PDF · -
  • 03 Sept 2024 10:57
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of schedule of Analysts/Institutional investors meet'.

    PDF · -
  • 31 Aug 2024 20:06
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 '.

    PDF · -
  • 31 Aug 2024 19:42
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015'.

    PDF · -
  • 29 Aug 2024 09:55
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 '.

    PDF · -
  • 22 Aug 2024 18:00
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015'.

    PDF · -
  • 22 Aug 2024 18:00
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015'.

    PDF · -
Older announcements →
Coming next in news
Arrives in Phase 3. Nothing here is estimated or filled in — we only show data we have.
  • Results & board-meeting calendar
  • Dividend, split, AGM calendar
  • Headlines with source and timestamp
  • Two-line factual filing summaries